An economic evaluation of the costs and benefits of heparin rationalisation in a hospital pharmacy

被引:0
|
作者
Penny Reeves
Jonathan Cooke
Adam Lloyd
Adam Hutchings
机构
[1] Fourth Hurdle Consulting Ltd,
[2] Wythenshawe Hospital,undefined
来源
Pharmacy World and Science | 2004年 / 26卷
关键词
Economics; Heparin; Hospital pharmacy; Pharmacy stock; United Kingdom;
D O I
暂无
中图分类号
学科分类号
摘要
Aim: To estimate the costs and benefits for a UK hospital pharmacy of stocking a single low molecular weight heparin (LMWH), enoxaparin, compared to stocking unfractionated heparin (UFH) and stocking both UFH and multiple different LMWHs.
引用
收藏
页码:160 / 168
页数:8
相关论文
共 50 条
  • [1] An economic evaluation of the costs and benefits of heparin rationalisation in a hospital pharmacy
    Reeves, P
    Cooke, J
    Lloyd, A
    Hutchings, A
    PHARMACY WORLD & SCIENCE, 2004, 26 (03): : 160 - 168
  • [2] ECONOMIC COSTS AND BENEFITS ASSOCIATED WITH A COMMUNITY PHARMACY ROTATION
    SELANDER, LK
    LARSON, LN
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 1995, 59 (01) : 7 - 14
  • [3] THE ECONOMIC-BENEFITS AND COSTS OF A NEW HOSPITAL
    DUSANSKY, R
    INGBER, M
    WALSH, J
    JOURNAL OF URBAN ANALYSIS, 1982, 7 (01): : 73 - 86
  • [4] Economic Evaluation of Hospital and Community Pharmacy Services
    Gammie, Todd
    Vogler, Sabine
    Babar, Zaheer-Ud-Din
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (01) : 54 - 65
  • [5] EVALUATION OF THE COSTS AND BENEFITS OF REDUCING HOSPITAL INFECTION
    DRUMMOND, MF
    DAVIES, LM
    JOURNAL OF HOSPITAL INFECTION, 1991, 18 : 85 - 93
  • [6] An evaluation of the economic benefits and costs of conservation tillage
    Uri, ND
    ENVIRONMENTAL GEOLOGY, 2000, 39 (3-4): : 238 - 248
  • [7] Automated hospital pharmacy supply chain and the evaluation of organisational impacts and costs
    Mathy, Caryn
    Pascal, C.
    Fizesan, M.
    Boin, C.
    Deleze, N.
    Aujoulat, O.
    SUPPLY CHAIN FORUM, 2020, 21 (03): : 206 - 218
  • [8] Costs and benefits of a formal quality framework for colonoscopy: Economic evaluation
    Pakneshan, Sahar
    Moy, Naomi
    O'Connor, Sam
    Hourigan, Luke
    Messmann, Helmut
    Shah, Ayesha
    Dulleck, Uwe
    Holtmann, G. J.
    ENDOSCOPY INTERNATIONAL OPEN, 2024, 12 (11) : E1334 - E1341
  • [9] Economic Evaluation of the Benefits and Costs of Disease Elimination and Eradication Initiatives
    Thompson, Kimberly M.
    Tebbens, Radboud J. Duintjer
    DISEASE ERADICATION IN THE 21ST CENTURY: IMPLICATIONS FOR GLOBAL HEALTH, 2011, : 115 - 130
  • [10] Effect of Carving in Pharmacy Benefits on Utilization and Costs
    Parekh, Natasha
    Papa, Sarah
    Drnach, Alek
    Spiegel, Laura
    Huang, Yan
    Manolis, Chronis
    Good, Chester B.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (10): : 1317 - 1324